Skip to main content
SpringerLink
Log in

Maternal Use of NSAID Drugs and Infant Congenital Malformations

  • Chapter
  • First Online:
Maternal Drug Use and Infant Congenital Malformations

Abstract

The literature on teratogenic effects of NSAID is large but inconsistent. Well-performed studies have indicated a moderately increased risk for cardiac defects after at least some NSAIDs and notably naproxen. There also seems to be an association between maternal use of the propionic acid derivatives ibuprofen and naproxen and infant cleft lip/palate, so far not seen for other NSAIDs. Avoidance of these drugs and notably naproxen in early pregnancy can be recommended but if exposure has occurred, the individual risk is low. Further data are needed on the use of coxibs in early pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bateman DN, McElhatton PR, Dickinson D, Wren C, Matthews JN, O’Keeffe M, Thomas SH. A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England. Eur J Pharmacol. 2004;60:635–41.

    CAS  Google Scholar 

  • Cassina M, De Santis M, Cesari E, van Eijkeren M, Berkovitch M, Eleftheriou G, Raffagnato E, Di Gianantonio E, Clementi M. First trimester diclofenac exposure and pregnancy outcome. Reprod Toxicol. 2010;30:401–4.

    Article  CAS  Google Scholar 

  • Cleves MA, Savell VH Jr, Raj S, Zhao W, Correa A, Werler MM, Hobbs CA, National Birth Defects Prevention Study. Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects. Birth Defects Res A Clin Mol Teratol. 2004;70:107–13.

    Article  CAS  Google Scholar 

  • Dathe K, Padberg S, Hulzsch S, Köhler L-M, Meixner K, Fietz A-K, Tissen-Diabate T, Meister R, Schaefer C. Exposure to cox-2 inhibitors (coxibs) during the 1st trimester and pregnancy outcome: a prospective observational cohort study. Eur J Clin Pharmacol. 2018;74:489–95.

    Article  CAS  Google Scholar 

  • Daniel S, Matok J, Gorodischer R, Koren G, Uziel E, Wiznitzer A, Levy A. Major malformations following exposure to nonsteroidal antinflammatory drugs during the first trimester of pregnancy. J Rheumatol. 2012;39:2163–9.

    Article  CAS  Google Scholar 

  • Ericson A, Källén B. Non-steroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol. 2001;15:371–5.

    Article  CAS  Google Scholar 

  • Hernandez R, Werler M, Romitti P, Sun L, Anderka M, The National Birth Defects Prevention Study. Nonsteroidal anti-inflammatory drug use among women and the risk of birth defects. Am J Obstet Gynecol. 2012;206:228.e1–8.

    Article  CAS  Google Scholar 

  • Interrante JD, Alles EC, Lind JN, Anderka M, Feldkamp ML, Werler MM, Taylor LG, Trinidad J, Gilboa SM, Broussard CS, National Birth Defects Prevention Study. Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study 1997-2011. Ann Epidemiol. 2017;27:645–53.

    Article  Google Scholar 

  • Källén B, Otterblad Olausson P. Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol. 2003;17:255–61.

    Article  Google Scholar 

  • Nezvalová-Henriksen K, Spigset O, Nordeng H. Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study. BJOG. 2013;120:948–59.

    Article  Google Scholar 

  • Nielsen GL, Sørensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001;322:266–70.

    Article  CAS  Google Scholar 

  • Ofori B, Oraichi D, Blais L, Rey E, Bérard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol. 2006;77:268–79.

    Article  CAS  Google Scholar 

  • Schoenfeld A, Bar Y, Merlob P, Ovaredia Y. NSAIDs: maternal and fetal considerations. Am J Reprod Immunol. 1992;28:141–7.

    Article  CAS  Google Scholar 

  • Van Gelder MMHJ, Roeleveld N, Nordeng H. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study. PLoS One. 2011;6:e22174. https://doi.org/10.1371/journal.pone.002174.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tornblad Institute for Comparative Embryology, Lund University, Lund, Sweden

    Bengt Källén

Authors
  1. Bengt Källén
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Källén, B. (2019). Maternal Use of NSAID Drugs and Infant Congenital Malformations. In: Maternal Drug Use and Infant Congenital Malformations. Springer, Cham. https://doi.org/10.1007/978-3-030-17898-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-17898-7_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-17897-0

  • Online ISBN: 978-3-030-17898-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation